BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23659864)

  • 1. Is oxytocin a therapeutic factor for ischemic heart disease?
    Alizadeh AM; Mirzabeglo P
    Peptides; 2013 Jul; 45():66-72. PubMed ID: 23659864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endogenous oxytocin in cardiac ischemic preconditioning.
    Alizadeh AM; Faghihi M; Sadeghipour HR; Mohammadghasemi F; Khori V
    Regul Pept; 2011 Feb; 167(1):86-90. PubMed ID: 21130120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart.
    Das B; Sarkar C
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):277-86. PubMed ID: 16495767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of central oxytocin in stress-induced cardioprotection in ischemic-reperfused heart model.
    Moghimian M; Faghihi M; Karimian SM; Imani A; Houshmand F; Azizi Y
    J Cardiol; 2013 Jan; 61(1):79-86. PubMed ID: 23159205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial protection from ischemia-reperfusion injury post coronary revascularization.
    Binder A; Ali A; Chawla R; Aziz HA; Abbate A; Jovin IS
    Expert Rev Cardiovasc Ther; 2015; 13(9):1045-57. PubMed ID: 26202544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
    Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healing the diabetic heart: does myocardial preconditioning work?
    Balakumar P; Sharma NK
    Cell Signal; 2012 Jan; 24(1):53-9. PubMed ID: 21945408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotection techniques: preconditioning, postconditioning and remote conditioning (basic science).
    Hausenloy DJ
    Curr Pharm Des; 2013; 19(25):4544-63. PubMed ID: 23270554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Realizing the clinical potential of ischemic preconditioning and postconditioning.
    Yellon DM; Hausenloy DJ
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning.
    Halkos ME; Kerendi F; Corvera JS; Wang NP; Kin H; Payne CS; Sun HY; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Ann Thorac Surg; 2004 Sep; 78(3):961-9; discussion 969. PubMed ID: 15337028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preconditioning the hyperlipidemic myocardium: fact or fantasy?
    Balakumar P; Babbar L
    Cell Signal; 2012 Mar; 24(3):589-95. PubMed ID: 22101013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective effect of resvaratrol pretreatment on myocardial ischemia-reperfusion induced injury in rats.
    Shen M; Jia GL; Wang YM; Ma H
    Vascul Pharmacol; 2006 Aug; 45(2):122-6. PubMed ID: 16765650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin exerts protective effects on in vitro myocardial injury induced by ischemia and reperfusion.
    Ondrejcakova M; Ravingerova T; Bakos J; Pancza D; Jezova D
    Can J Physiol Pharmacol; 2009 Feb; 87(2):137-42. PubMed ID: 19234577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.
    Sivarajah A; McDonald MC; Thiemermann C
    Shock; 2006 Aug; 26(2):154-61. PubMed ID: 16878023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconditioning with Porphyromonas gingivalis lipopolysaccharide may confer cardioprotection and improve recovery of the electrically induced intracellular calcium transient during ischemia and reperfusion.
    Fan MH; Wong KL; Wu S; Leung WK; Yam WC; Wong TM
    J Periodontal Res; 2010 Feb; 45(1):100-8. PubMed ID: 19602110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts.
    Balakumar P; Singh H; Reddy K; Anand-Srivastava MB
    J Cardiovasc Pharmacol; 2009 Sep; 54(3):204-12. PubMed ID: 19568176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotective effects of an active metabolite of furnidipine in 2 models of isolated heart and on in vivo ischemia–induced and reperfusion-induced arrhythmias in rats.
    Krzemiński TF; Mitrega K; Varghese B; Hudziak D; Porc M; Kedzia A; Sielańczyk AW; Jabłecka A; Jasiński M
    J Cardiovasc Pharmacol; 2011 Feb; 57(2):183-93. PubMed ID: 21052014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies.
    Dirksen MT; Laarman GJ; Simoons ML; Duncker DJ
    Cardiovasc Res; 2007 Jun; 74(3):343-55. PubMed ID: 17306241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiology and pharmacology of myocardial preconditioning and postconditioning.
    Huffmyer J; Raphael J
    Semin Cardiothorac Vasc Anesth; 2009 Mar; 13(1):5-18. PubMed ID: 19329471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.